Cipher Pharmaceuticals

Cipher Pharmaceuticals EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Cipher Pharmaceuticals (CPH.TO) as of Oct 31, 2026 is 16.87 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 11.87 M USD — a change of 42.14% (higher).

EBITDA

16.87 MUSD

YoY

42.14%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Cipher Pharmaceuticals is 2025 16.87 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Cipher Pharmaceuticals was 2024 11.87 M USD. It decreases by 42.14% higher compared to the previous year.

The Cipher Pharmaceuticals EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
5.51 M USD
Jan 1, 2019
11.68 M USD
Jan 1, 2020
12.20 M USD
Jan 1, 2021
11.82 M USD
Jan 1, 2022
13.03 M USD
Jan 1, 2023
12.76 M USD
Jan 1, 2024
11.87 M USD
Jan 1, 2025
16.87 M USD
The Cipher Pharmaceuticals EBITDA history
YEAREBITDAYoY
16.87 MUSD+42.14%
11.87 MUSD-6.98%
12.76 MUSD-2.10%
13.03 MUSD+10.22%
11.82 MUSD-3.07%
12.20 MUSD+4.41%
11.68 MUSD+112.00%
5.51 MUSD-78.29%
25.38 MUSD+260.27%
7.05 MUSD-10,460.29%
-68,000.00USD-98.36%
-4.14 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cipher Pharmaceuticals Stock analysis

What does Cipher Pharmaceuticals do? Cipher Pharmaceuticals Inc. is a Canadian pharmaceutical company specializing in the development, marketing, and distribution of medications. The company was founded in 1999 and is headquartered in Oakville, Ontario, Canada. Translator note: The translation provided above is a faithful rendering of the German text into English. Cipher Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cipher Pharmaceuticals stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Cipher Pharmaceuticals is 16.87 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Cipher Pharmaceuticals changed from 11.87 M USD to 16.87 M USD, representing a 42.14% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Cipher Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Cipher Pharmaceuticals historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Cipher Pharmaceuticals

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Cipher Pharmaceuticals